The “Translational Unraveling of Precision Acute Care (TUPAC)” research team at CHU de Clermont-Ferrand (Pr. Matthieu Jabaudon & Pr. Marc Garnier) is recruiting a post-doctoral researcher to lead a 3-year project on acute respiratory distress syndrome (ARDS): development of a macrophage-reprogramming therapy using targeted nanoparticles in preclinical models (in vitro/ex vivo/in vivo), prospective multicenter clinical cohort for multimodal and longitudinal phenotyping.
✅ PhD in cell/molecular biology, life sciences, medicine or a related field
✅ Experience in animal experimentation (FELASA Level B) and/or translational clinical research is a plus
📍 Clermont-Ferrand University Hospital — within the iGReD (Institut de Génétique, Reproduction et Développement) translational ecosystem and the upcoming Clinical Investigation Center (#CIC) 2027–2032 project
INSERM Inserm Auvergne-Rhône-Alpes Direction générale de l’offre de soins (DGOS) Université Clermont Auvergne Institut SVSAE UCA (Sciences de la Vie, Santé, Agronomie, Environnement) UFR de Médecine et des Professions Paramédicales
📅 3-year contract — preferred start (flexible): October 2026
Driven and eager to join a growing research team? Get in touch!
More details 👉 here
Tagged as: Life Sciences
Postdoctoral position in Neural Circuit Development Pinto Teixeira Lab Laboratory for the study of neural circuit development Center for Integrative...
ApplyPostdoctoral Position in Machine Learning for Peptide Membrane Permeability PredictionLocation: GEC Laboratory, CNRS/Picardie University, Amiens, FranceDuration: 12 months (start date...
ApplyPlease send your application to mjabaudon@chu-clermontferrand.fr
Don't forget to mention that you found the position on jobRxiv!
